MIDDLE JURASSIC - EARLY CRETACEOUS INTEGRATED BIOSTRATIGRAPHY (AMMONITES, CALCAREOUS NANNOFOSSILS AND CALPIONELLIDS) OF THE CONTRADA DIESI SECTION (SOUTH-WESTERN SICILY, ITALY)

Facies and biostratigraphic analyses of the Contrada Diesi succession, cropping out along the northern slope of Mt. Magaggiaro (Sciacca, SW Sicily), provided new data on the Middle Jurassic-Early Cretaceous pelagic sedimentation in the Saccense domain. The richness in ammonites allowed the identification of Bathonian-Kimmeridgian Biozones and Subzones, while the Tithonian-Valanginian interval was defined mainly by calpionellids and calcareous nannofossils. Facies and microbiofacies analyses of the Jurassic-Cretaceous pelagic sediments of the area, together with ammonite, calpionellid and calcareous nannofossil integrated biostratigraphy, were very effective tools for comparison of biostratigraphic events. Many gaps in sedimentation were recognized, the most important spanning the middle and late Berriasian and part of the early Berriasian. The Contrada Diesi succession provides new litho-biostratigraphic data on the Saccense Domain. It suggests a high degree of internal variability tied to the irregular paleotopography of the carbonate platform substrate (Inici Fm.), derived from Early Jurassic tectonics. Gaps in sedimentation in the Contrada Diesi sections indicate that the environment of the Saccense Domain was characterized by a variable rate of sedimentation and energy changes

MIDDLE JURASSIC - EARLY CRETACEOUS INTEGRATED BIOSTRATIGRAPHY (AMMONITES, CALCAREOUS NANNOFOSSILS AND CALPIONELLIDS) OF THE CONTRADA DIESI SECTION (SOUTH-WESTERN SICILY, ITALY)

Facies and biostratigraphic analyses of the Contrada Diesi succession, cropping out along the northern slope of Mt. Magaggiaro (Sciacca, SW Sicily), provided new data on the Middle Jurassic-Early Cretaceous pelagic sedimentation in the Saccense domain. The richness in ammonites allowed the identification of Bathonian-Kimmeridgian Biozones and Subzones, while the Tithonian-Valanginian interval was defined mainly by calpionellids and calcareous nannofossils. Facies and microbiofacies analyses of the Jurassic-Cretaceous pelagic sediments of the area, together with ammonite, calpionellid and calcareous nannofossil integrated biostratigraphy, were very effective tools for comparison of biostratigraphic events. Many gaps in sedimentation were recognized, the most important spanning the middle and late Berriasian and part of the early Berriasian. The Contrada Diesi succession provides new litho-biostratigraphic data on the Saccense Domain. It suggests a high degree of internal variability tied to the irregular paleotopography of the carbonate platform substrate (Inici Fm.), derived from Early Jurassic tectonics. Gaps in sedimentation in the Contrada Diesi sections indicate that the environment of the Saccense Domain was characterized by a variable rate of sedimentation and energy changes

FCR (Fludarabine, Cyclophosphamide, Rituximab) regimen followed by 90yttrium ibritumomab tiuxetan consolidation for the treatment of relapsed grades 1 and 2 follicular lymphoma: a report of 9 cases

<p>Abstract</p> <p>Background</p> <p>This retrospective analysis is focused on the efficacy and safety of radioimmunotherapy (RIT) with Zevalin^®in nine patients with recurrent follicular lymphoma (FL) who were treated in a consolidation setting after having achieved complete remission or partial remission with FCR.</p> <p>Methods</p> <p>The median age was 63 yrs (range 46-77), all patients were relapsed with histologically confirmed CD20-positive (grade 1 or 2) FL, at relapse they received FCR every 28 days: F (25 mg/m²x 3 days), C (1 gr/m²day 1) and R (375 mg/m²day 4) for 4 cycles. Who achieved at least a partial remission, with < 25% bone marrow involvement, was treated with ⁹⁰Yttrium Ibritumomab Tiuxetan 11.1 or 14.8 MBq/Kg up to a maximum dose 1184 MBq, at 3 months after the completion of FCR. The patients underwent a further restaging at 12 weeks after ⁹⁰Y-RIT with total body CT scan, FDG-PET/CT and bilateral bone marrow biopsy.</p> <p>Results</p> <p>Nine patients have completed the treatment: FCR followed by ⁹⁰Y-RIT (6 patients at 14.8 MBq/Kg, 3 patients at 11.1 MBq/Kg). After FCR 7 patients obtained CR and 2 PR; after ⁹⁰Y-RIT two patients in PR converted to CR 12 weeks later. With median follow up of 34 months (range 13-50) the current analysis has shown that overall survival (OS) is 89% at 2 years, 76% at 3 years and 61% at 4 years. The most common grade 3 or 4 adverse events were hematologic, one patient developed herpes zoster infection after 8 months following valacyclovir discontinuation; another patient developed fungal infection.</p> <p>Conclusions</p> <p>Our experience indicate feasibility, tolerability and efficacy of FCR regimen followed by ⁹⁰Y-RIT in patients relapsed with grades 1 and 2 FL with no unexpected toxicities. A longer follow up and a larger number of patients with relapsed grades 1 and 2 FL are required to determine the impact of this regimen on long-term duration of response and PFS.</p

Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-ras gene mutation

<p>Abstract</p> <p>Background</p> <p>Serum levels of IGF-I in patients affected with multiple myeloma (MM) have been scarcely studied. The present study is aimed to explore this point comparing 55 healthy subjects, 71 monoclonal gammopaties of uncertain significance (MGUS) and 77 overt MM patients. In the same subjects, basic FGF and VEGF, have been detected. All three mediators were analyzed in function of K-<it>ras </it>mutation and melphalan response. Concerning IGF-I, two representative monitoring examples have also been added.</p> <p>Methods</p> <p>Cytokine determinations were performed by commercially available ELISA kits, while K12-<it>ras </it>mutation was investigated on genomic DNA isolated from bone marrow cell specimens by RFLP-PCR assay.</p> <p>Results</p> <p>Significant reductions of IGF-I levels were observed in MGUS and MM as compared with healthy controls. In addition, MM subjects showed significantly decreased serum IGF-I levels than MGUS. Conversely, increasing levels were observed for bFGF and VEGF, molecules significantly correlated. A multivariate analysis corrected for age and gender confirmed the significant difference only for IGF-I values (P = 0.01). K12-<it>ras </it>mutation was significantly associated with malignancy, response to therapy and with significantly increased serum bFGF levels.</p> <p>Conclusion</p> <p>IGF-I reduction in the transition: Controls→MGUS→MM and changes observed over time suggest that IGF-I should be furtherly studied in future clinical trials as a possible monitoring marker for MM.</p

Mass-transport deposits from the Toarcian of the Umbria-Marche-Sabina Basin (Central Italy)

Mass-transport deposits (MTDs) intercalated in slope/basinal successions, produced by submarine collapses and mass flows, are generally constituted of allochthonous elements sourced from platform margins. Here we present a noticeable exception where Toarcian calciclastic deposits made of pelagic carbonate elements are embedded in other pelagic carbonates. Selected outcrops pertaining to the Rosso Ammonitico Fm of three different pelagic carbonate platform (PCP)-basin systems were studied. The pelagic successions of the study areas onlap Early Jurassic structural highs. These clastic bodies partially replace the typical Toarcian reddish marls and shales of the Umbria-Marche-Sabina palaeogeographic Domain at different stratigraphic levels. The clasts range from blocks to megablocks; extraclasts of Corniola facies (Pliensbachian) and, sporadically, of Calcare Massiccio peritidal carbonates (Hettangian) are associated with Rosso Ammonitico intraclasts. The internal architecture of the MTDs and their emplacement processes, as well as their source and accumulation areas, were identified. Three distinct lithofacies characterise the clastic bodies, each one corresponding to a different emplacement process or to a different portion of the flow. The occurrence of lithified megablocks (&gt;20 m across) of Corniola Fm suggests the exhumation of the buried portion of the unit. Synsedimentary extensional tectonics is the most likely triggering mechanism. Sedimentological analysis, coupled with geological mapping of the study areas, reveals the key role played by PCPs in the genesis of these MTDs. The early Toarcian reactivation of Hettangian palaeofaults bounding the structural highs is inferred. These faults, characterised by moderate offsets, crosscut the onlap wedges of the hangingwall successions, exhuming the older and lithified portion of Corniola Fm. Once became inactive, the fault planes were then eroded producing palaeoescarpments. Their backstepping, coupled with seismic shocks, produced the accumulation of the study clastic bodies

High doses of ara-C and m-AMSA in the treatment of refractory acute non lymphocytic leukemia.

From November, '85 to March, '87, 17 patients (12 males and 5 females, median 28 years) with resistant or relapsed ANLL received HiDAC (3 g/m2 c.i. 3 hs every 12 hs, day 1-4) + m-AMSA (100 mg/m2 i.v. day 5-7) as salvage therapy: 8/17 patients (47.1%) achieved CR, 7/17 (41.1%) were resistant and 2/17 (11.8%) died during induction; 8/10 relapsed patients achieved a 2nd CR, while all 7 primary resistant patients failed to. Median period of PMN less than 0.5 x 10(9)/l was 28 days, median period of PLTS less than 30 x 10(9)/l was 25 days. All patients had infections during aplasia. Median CR duration was 6.6 months, while median survival of responders was 10.6 months. Two patients with severe induction-related complications relapsed after 2 and 5 months, respectively: 1 patient underwent BMT and relapsed after 21 months; 5 patients, 4 of whom had received a prior ABMT during 1st CR, underwent ABMT: 3 died from ABMT related toxicity and 2 relapsed after 8 and 18 months, respectively. We conclude that HiDAC + m-AMSA is highly effective in relapsed, but not in resistant patients with acceptable hematologic and extra-hematologic toxicity. The role and modalities of ABMT in prolonging a 2nd CR are at present controversial